Pharma-Godfroid: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Pharma-Godfroid
NACE 70.200, Business and other management consultancy
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€49,341
2024 · €50,415-€1,074
Equity
€227,277
2024 · €177,936+€49,341
Cash
€24,953
2024 · €27,548-€2,596
Balance sheet total
€832,624
2024 · €828,883+€3,741
Largest movements
Assets
No asset line moved by more than 1% of the balance sheet total.
Equity and liabilities
- Profit (loss) carried forward +€49,341
up €49,341 (+28.0%), from €175,936 to €225,277
- Debts after one year -€46,667
down €46,667 (-7.9%), from €593,889 to €547,222
Income statement
- Taxes +€964
up €964 (+4.9%), from €19,660 to €20,624
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€50,415
Gross operating margin
-€396
Depreciation
+€9
Other operating charges
-€220
Financial charges
+€496
Taxes
-€964
Result 2025
€49,341
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€45,009
Investment
-€938
Financing
-€46,667
Cash 2024
€27,548
From operations (derived)
+€45,009
Net result for the year
+€49,341
Depreciation
+€1,220
Receivables within one year
-€6,751
Deferred charges and accrued income
+€132
Trade debts
+€385
Tax, wage and social debts
+€1,988
Other debts
-€1,306
Investment (derived)
-€938
Investment in fixed assets (net)
-€938
Financing
-€46,667
Debts after one year
-€46,667
Cash 2025
€24,953
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €828,883 | €832,624 | +€3,741 | +0.5% |
| Fixed assets | 21/28 | €798,315 | €798,033 | -€282 | 0.0% |
| Tangible fixed assets | 22/27 | €1,848 | €1,566 | -€282 | -15.2% |
| Plant, machinery and equipment | 23 | €172 | €637 | +€465 | +270% |
| Furniture and vehicles | 24 | €1,676 | €929 | -€747 | -44.6% |
| Financial fixed assets | 28 | €796,467 | €796,467 | = | 0.0% |
| Current assets | 29/58 | €30,568 | €34,591 | +€4,023 | +13.2% |
| Amounts receivable within one year | 40/41 | €2,888 | €9,638 | +€6,751 | +234% |
| Trade receivables | 40 | €2,500 | €0 | -€2,500 | -100% |
| Other amounts receivable | 41 | €388 | €9,638 | +€9,251 | +2,387% |
| Cash at bank and in hand | 54/58 | €27,548 | €24,953 | -€2,596 | -9.4% |
| Deferred charges and accrued income | 490/1 | €132 | €0 | -€132 | -100% |
| Total equity and liabilities | 10/49 | €828,883 | €832,624 | +€3,741 | +0.5% |
| Equity | 10/15 | €177,936 | €227,277 | +€49,341 | +27.7% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €175,936 | €225,277 | +€49,341 | +28.0% |
| Amounts payable | 17/49 | €650,947 | €605,346 | -€45,600 | -7.0% |
| Amounts payable after more than one year | 17 | €593,889 | €547,222 | -€46,667 | -7.9% |
| Financial debts | 170/4 | €593,889 | €547,222 | -€46,667 | -7.9% |
| Amounts payable within one year | 42/48 | €56,183 | €57,249 | +€1,066 | +1.9% |
| Current portion of amounts payable after more than one year | 42 | €46,667 | €46,667 | = | 0.0% |
| Trade debts | 44 | €771 | €1,156 | +€385 | +50.0% |
| Suppliers | 440/4 | €771 | €1,156 | +€385 | +50.0% |
| Taxes, remuneration and social security | 45 | €7,439 | €9,427 | +€1,988 | +26.7% |
| Taxes | 450/3 | €7,439 | €9,427 | +€1,988 | +26.7% |
| Other amounts payable | 47/48 | €1,306 | €0 | -€1,306 | -100% |
| Accrued charges and deferred income | 492/3 | €875 | €875 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,228 | €1,220 | -€9 | -0.7% |
| Other operating charges | 640/8 | €698 | €918 | +€220 | +31.5% |
| Gross operating margin | 9900 | €79,887 | €79,491 | -€396 | -0.5% |
| Operating profit (loss) | 9901 | €77,961 | €77,354 | -€607 | -0.8% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €7,885 | €7,389 | -€496 | -6.3% |
| Recurring financial charges | 65 | €7,885 | €7,389 | -€496 | -6.3% |
| Profit (loss) for the period before taxes | 9903 | €70,076 | €69,965 | -€111 | -0.2% |
| Income taxes | 67/77 | €19,660 | €20,624 | +€964 | +4.9% |
| Profit (loss) for the period | 9904 | €50,415 | €49,341 | -€1,074 | -2.1% |
| Profit (loss) for the period to be appropriated | 9905 | €50,415 | €49,341 | -€1,074 | -2.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.